JAAQ secures $17 million to integrate clinically regulated mental health material.

      The London-based platform, which currently supports 1.5 million eligible lives across enterprise and healthcare implementations, is utilizing its Series A funding to expedite its entry into the US market and enhance its clinical infrastructure, accompanied by a new CEO who previously sold his company to Adobe.

      JAAQ, the digital health engagement platform from London, has successfully secured $17 million in a Series A funding round. This investment, which includes contributions from Meridian Health Ventures, Fuel Ventures, Bolt Angels, and Guinness Ventures, is aimed at scaling enterprise partnerships, strengthening clinical infrastructure, and expanding into the United States. Dr. Pooja Sikka, a partner at Meridian Health Ventures, has joined the company’s board as part of this agreement.

      Founded in 2021, JAAQ initially operated on a direct-to-consumer model focused on video-based mental health content. It has since shifted to an enterprise and healthcare approach, incorporating its library of over 10,000 clinically reviewed videos into the digital products offered by insurers, employers, and healthcare organizations instead of distributing it directly to users.

      The rationale is structural: JAAQ integrates its content into the apps and services that people already use rather than asking them to search for a mental health platform. The company currently serves over 1.5 million eligible lives through active enterprise deployments.

      Alex Packham has been appointed as CEO to guide the company through its next phase. He is well-known for founding ContentCal, a social media management SaaS platform that he sold to Adobe in December 2021, after which he spent three years overseeing its integration into Adobe before leaving.

      The platform's business offering has two components. Organizations can either license content from JAAQ’s library to incorporate it into their own product journeys or license a customized hosted JAAQ experience.

      Additionally, the company is developing what it refers to as a “clinical engagement layer” for AI-native products, allowing any digital product or team to seamlessly integrate governed mental health content into user journeys without having to establish their own clinical governance framework.

      The appeal to enterprises addresses two challenges simultaneously: bridging the mental health access gap and increasing engagement with wellbeing benefits that organizations invest in but employees seldom utilize.

      The clinical governance approach is key to JAAQ's differentiation from generic AI wellness tools. The content produced on the platform is created within a clearly defined clinical and creative framework rather than being generated on demand, and the appointment of Johri is meant to convey that the product is designed with intrinsic clinical credibility.

      Meridian Health Ventures, which specifically targets UK health technology with pathways into the US market, is well-suited to support this positioning; the firm manages the first NHS-anchored venture fund and has a dedicated Innovations in Mental Health Fund.

      The strategic aim of the funding is to facilitate US expansion. The validation received from the UK market is significant, with the company’s website highlighting case studies like a UK bank that saved £896,000 due to improved employee productivity and wellbeing, and an insurer that offset the equivalent of twelve full-time customer service positions through content delivered by JAAQ.

      Adapting this model to the US employer and health insurer landscape, where mental health benefits are increasingly prioritized at the board level but engagement continues to be a challenge, presents the next significant test.